Impact of dialysis technique on renal anemia

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Hematology

Background:

• Cardiovascular disease (CVD) is a major cause of mortality in chronic kidney disease (CKD) patients, especially those on hemodialysis (HD).
• Anemia is a common complication in CKD, linked to reduced survival and adverse cardiovascular outcomes across all stages of kidney disease.
• The interplay between CKD, anemia, inflammation, and CVD requires further investigation, particularly concerning the impact of dialysis modalities.

Purpose of the Study:

• To review the current understanding of how different dialysis techniques influence renal anemia in CKD patients.
• To explore the potential benefits of high-efficiency on-line hemodiafiltration (HDF) in managing anemia and associated complications in HD patients.
• To examine the relationship between dialysis modality, anemia, inflammation, and cardiovascular health in CKD.

Main Methods:

• Review of existing clinical studies and scientific literature.
• Analysis of data comparing on-line hemodiafiltration (HDF) with conventional hemodialysis (HD).
• Investigation into the mechanisms by which convective dialysis methods may affect anemia and inflammation.

Main Results:

• High-efficiency on-line HDF has demonstrated potential in improving anemia and reducing the requirement for erythropoietin-stimulating agents in HD patients.
• Convective dialysis techniques may remove protein-bound erythropoietic inhibitors, contributing to anemia improvement.
• Anemia improvement in patients undergoing on-line HDF is associated with a reduction in the inflammatory state characteristic of uremic syndrome.

Conclusions:

• Dialysis technique, particularly high-efficiency on-line HDF, may play a significant role in managing renal anemia in CKD patients.
• On-line HDF shows promise in mitigating anemia and associated inflammation, potentially impacting cardiovascular outcomes in HD patients.
• Further research is warranted to fully elucidate the benefits of HDF on anemia, inflammation, and long-term survival in CKD.